Show filters
Resources type
Filter by Resources type
Pathologies
Filter by Pathologies
Technologies
Filter by Technologies
Instruments
Filter by Instruments
98 result(s) found
Sort by:

Sebia launches M-inSight®, a test for monitoring multiple myeloma patients

Press release
Dec. 04, 2023

Corgenix, a Sebia Group company, CAP/CLIA clinical laboratory, positions Sebia to globally commercialize M-inSight®, a novel non-invasive liquid biopsy assay for Minimal Residual Disease (MRD) monitoring in multiple myeloma

Dec. 09, 2023 Nov. 11, 2023

Event
San Diego, CA

ASH 2023

Sebia booth: #2455

Learn more

Current Status of Detecting Monoclonal Antibodies and Free Light Chains in Serum

Webinar
Aug. 31, 2023

Educational Webinar with Dr. Matthias Orth from University of Heidelberg at University Hospital Mannheim.

Improving the diagnosis of AATD with aid of Serum Protein Electrophoresis

Webinar
Aug. 23, 2023

Educational Workshop with Dr. Ilaria Ferrarotti

Sep. 27, 2023 Sep. 30, 2023

Event
Athens, Greece

IMS 2023

Sebia booth: #211

Learn more

Sep. 27, 2023 Sep. 30, 2023

Event
Athens, Greece

IMS 2023

Sebia booth: #211

Learn more

Aug. 27, 2023 Aug. 31, 2023

Event
Roma, Italy

TIAFT 2023

Sebia booth: #8

Learn more

Aug. 27, 2023 Aug. 31, 2023

Event
Roma, Italy

TIAFT 2023

Sebia booth: #8

Learn more